Azar: COVID-19 therapeutic data for emergency use could be weeks away

Modern Healthcare: HHS Secretary Alex Azar on Friday said that data that could allow for emergency authorization of experimental COVID-19 therapeutics could be available in a matter of weeks.

Azar made the comments during a congressional hearing conducted by the House Select Subcommittee on the Coronavirus Crisis when Rep. Blaine Luetkemeyer (R-Mo.) asked about promising preliminary results from trials on an experimental Regeneron drug that is being developed to treat less severe cases of COVID-19.

Read article